Literature DB >> 10597218

The generation of nfkb2 p52: mechanism and efficiency.

M Heusch1, L Lin, R Geleziunas, W C Greene.   

Abstract

nfkb2 encodes two members of the NF-kappa B/Rel family of proteins: p52 and p100. The p100 polypeptide has been proposed to serve as a precursor of p52, which corresponds to the N-terminal half of p100. While p52 functions as a Rel transcription factor, the larger p100 protein acts as a cytoplasmic inhibitor of select NF-kappa B/Rel transcription factor complexes. Because of their distinct functions, we have studied the biochemical basis for the production of these two nfkb2-derived gene products. Like the p50 product of the nfkb1 gene, p52 is principally generated in a cotranslational manner involving proteolytic processing by the proteasome. The generation of p52 is dependent on a glycine-rich region (GRR) located upstream of the p52 C-terminus, and repositioning of this GRR alters the location of proteasome processing. In most cells, small amounts of p52 are produced relative to the levels of p100, unlike the usually balanced production of nfkb1-derived p50 and p105. Using p100/p105 chimeras containing different segments of the nfkb1 and nfkb2 genes, we have found that diminished p52 processing is a property conferred by peptide sequences located downstream of the GRR, flanking the site of p52 processing.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10597218     DOI: 10.1038/sj.onc.1203022

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  38 in total

1.  SCF(beta)(-TrCP) ubiquitin ligase-mediated processing of NF-kappaB p105 requires phosphorylation of its C-terminus by IkappaB kinase.

Authors:  A Orian; H Gonen; B Bercovich; I Fajerman; E Eytan; A Israël; F Mercurio; K Iwai; A L Schwartz; A Ciechanover
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha.

Authors:  G Xiao; M E Cvijic; A Fong; E W Harhaj; M T Uhlik; M Waterfield; S C Sun
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

3.  Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism.

Authors:  Benjamin Mordmüller; Daniel Krappmann; Meral Esen; Elmar Wegener; Claus Scheidereit
Journal:  EMBO Rep       Date:  2003-01       Impact factor: 8.807

4.  The p50-p50 NF-kappaB complex as a stimulus-specific repressor of gene activation.

Authors:  Xin Tong; Lei Yin; Raymond Washington; Daniel W Rosenberg; Charles Giardina
Journal:  Mol Cell Biochem       Date:  2004-10       Impact factor: 3.396

5.  Evidence for the direct involvement of {beta}TrCP in Gli3 protein processing.

Authors:  Baolin Wang; Yanyun Li
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

Review 6.  RelB: an outlier in leukocyte biology.

Authors:  Patrick Millet; Charles McCall; Barbra Yoza
Journal:  J Leukoc Biol       Date:  2013-08-06       Impact factor: 4.962

Review 7.  The NF-kappaB family of transcription factors and its regulation.

Authors:  Andrea Oeckinghaus; Sankar Ghosh
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10       Impact factor: 10.005

8.  Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha.

Authors:  V Heissmeyer; D Krappmann; E N Hatada; C Scheidereit
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

9.  Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.

Authors:  Yinghui Li; Qi-Ling Zhou; Wenjie Sun; Prashant Chandrasekharan; Hui Shan Cheng; Zhe Ying; Manikandan Lakshmanan; Anandhkumar Raju; Daniel G Tenen; Shi-Yuan Cheng; Kai-Hsiang Chuang; Jun Li; Shyam Prabhakar; Mengfeng Li; Vinay Tergaonkar
Journal:  Nat Cell Biol       Date:  2015-09-21       Impact factor: 28.824

10.  Balance between NF-κB p100 and p52 regulates T cell costimulation dependence.

Authors:  Maria Letizia Giardino Torchia; Dietrich B Conze; Dragana Jankovic; Jonathan D Ashwell
Journal:  J Immunol       Date:  2012-12-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.